FOSUN PHARMA 02196Hong Kong Stock Exchange

17.8700.28%( +0.050 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
FOSUN PHARMA (02196) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2012-10-30
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100001M79
Southbound Connect
Shanghai · Shenzhen

Related Securities

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)48.66B4/112
Net Profit (Last FY)3.95B10/125
ROE (Last FY)6.92%37/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Executive Director
陈玉卿 Executive Director
关晓晖 Executive Director
文德镛 Executive Director
王可心 Executive Director
刘毅 Executive Director
陈启宇 Non-Executive Director
潘东辉 Non-Executive Director
余梓山 Independent Non-Executive Director
王全弟 Independent Non-Executive Director
Chen Penghui Independent Non-Executive Director
杨玉成 Independent Non-Executive Director
严佳 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-12-02.

About this page

This page shows FOSUN PHARMA (02196) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.